Recently, female patients with de novo missense variants and de novo protein truncating variants in MED12 were described, resulting in a clinical spectrum centered around ID and Hardikar syndrome without ID. The gene discussed is MED12; the disease is cholestasis-pigmentary retinopathy-cleft palate syndrome.